Your browser doesn't support javascript.
loading
Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07.
Kim, Seung Tae; Kim, Sun Young; Lee, Jeeyun; Yun, Seong Hyeon; Kim, Hee Cheol; Lee, Woo Yong; Kim, Tae Won; Hong, Yong Sang; Lim, Seok-Byung; Baek, Ji Yeon; Oh, Jae Hwan; Ahn, Joong Bae; Shin, Sang Joon; Han, Sae-Won; Kim, Seong Geun; Kang, Seok Yun; Sym, Sun Jin; Zang, Dae Young; Kim, Yeul Hong; Choi, In Sil; Kang, Jung Hun; Kim, Min-Ji; Park, Young Suk.
Afiliação
  • Kim ST; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea.
  • Kim SY; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee J; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • Yun SH; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea.
  • Kim HC; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea.
  • Lee WY; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea.
  • Kim TW; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea.
  • Hong YS; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Baek JY; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Oh JH; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • Ahn JB; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
  • Shin SJ; Yonsei University College of Medicine, Seoul, Korea.
  • Han SW; Yonsei University College of Medicine, Seoul, Korea.
  • Kim SG; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Kang SY; Good Gangan Hospital Cancer Center, Pusan, South Korea.
  • Sym SJ; Ajou University School of Medicine, Suwon, South Korea.
  • Zang DY; Gachon University Gil Hospital, Incheon, Korea.
  • Kim YH; Hallym University Medical Center, Hallym University, Anyang, Korea, South Korea.
  • Choi IS; Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
  • Kang JH; Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
  • Kim MJ; Gyeongsang National University, Jinju, Korea.
  • Park YS; Statistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea.
J Clin Oncol ; 40(33): 3868-3877, 2022 11 20.
Article em En | MEDLINE | ID: mdl-35772045
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Neoplasias do Colo / Oxaliplatina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Neoplasias do Colo / Oxaliplatina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article